Evan Lockwood Rachlin
Disclosed holdings of Evan Lockwood Rachlin as of 2026-10-16: 58K shares of Iambic Therapeutics (IAM), worth about $944K at the last close. In 12 months…
What Evan Lockwood Rachlin reported holding
As of the latest filing on , Evan Lockwood Rachlin reported holding 57,754 shares of Iambic Therapeutics (IAM), worth about $944K at the last close of $16 (Oct 19, 2026), held through a see footnote. In the last 12 months, Evan Lockwood Rachlin bought $11.5M in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Iambic Therapeutics IAM | 57,754 | 58K see footnote | $16 | $944K | Oct 16, 2026 |
Is this Evan Lockwood Rachlin’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2026
Evan Lockwood Rachlin bought shares on the open market in 2026.
Evan Lockwood Rachlin reported 1 open-market purchase and 0 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The company behind these filings
- Iambic Therapeutics IAM
Evan Lockwood Rachlin reported 1 open-market purchase and 0 sales here, 2026.
- Last close
- $16.34
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Evan Lockwood Rachlin's trades
Has Evan Lockwood Rachlin bought shares on the open market?
Evan Lockwood Rachlin bought shares on the open market in 2026.
When did Evan Lockwood Rachlin last buy or sell shares?
In SEC filings since 2026: the latest open-market purchase is from 2026; no open-market sale is on record.
Which companies has Evan Lockwood Rachlin traded as an insider?
Iambic Therapeutics (IAM), from 2026 to 2026: 1 purchase and 0 sales.